Steep Hill, the industry leader in cannabis testing and analytics in the US and internationally, will open a full service medical cannabis quality assurance laboratory, bringing advanced scientific tools and methodology to the state, for regulatory oversight of cannabis, in Albuquerque, New Mexico.
According to the firm, Steep Hill is currently the only laboratory licensed by the New Mexico Department of Health to conduct potency and contaminant testing in order to meet the recently adopted regulatory requirements pertaining to cannabis safety for medical patients in New Mexico.
"We are excited to bring our entire suite of products to New Mexico, including our QuantaCann2, an advanced cloud-based potency monitoring system. This will enable the state to meet its THC and CBD testing requirements, while also providing regulators with a real time window into the marketplace," said David Lampach, CEO/Co-Founder of Steep Hill.
The State of New Mexico requires regular testing be done in a Department of Health approved laboratory as the only acceptable method to determine the quality, purity and potency required for the sale of medical cannabis products.
Founded in Oakland, California, in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics in the US and abroad. Steep Hill moved its U.S. headquarters to a larger facility in Berkeley, California, in January 2015.